Literature DB >> 25445415

Validation and evaluation of eight commercially available point of care CRP methods.

Nannette Brouwer1, Johannes van Pelt2.   

Abstract

BACKGROUND: There are several situations compelling to measure CRP with a point of care (POC) method. Assay performance of various available POC CRP methods were evaluated as analytical quality is important and should be known before clinical use.
METHODS: We compared 2 semi-quantitative strips; Actim and Cleartest and 6 quantitative CRP tests; Afinion, QuikRead go, Smart, iChroma, Microsemi and AQT90 Flex to the Synchron CRP method, using the CLSI EP9 protocol. The coefficient of variance (CV) was determined. Various aspects of pre-analytical and analytical steps were evaluated.
RESULTS: CRP strips showed 50-60% concordance with the Synchron CRP. The linear regression lines (95% CI) of the quantitative POC CRP methods compared to the Synchron CRP method were: y=[0.96-1.04]x+[-4.7 to -2.04] (Smart); y=[1.00-1.06]x+[1.05-4.99] (AQT90 Flex), y=[0.84-0.91]x+[-1.13 to 3.95] (Afinion); y=[0.83-0.87]x+[0.25-1.5] (QuikRead go); y=[0.76-0.82]x+[-0.18 to 1.35] (iChroma) and y=[1.14-1.18]x+[-3.17 to -1.83] (Microsemi).
CONCLUSIONS: At best, the semi-quantitative CRP strips could be used to discriminate between normal and increased levels of CRP. Of the quantitative methods, when combining analytical with practical evaluation, the Smart and Afinion would be the preferred analyzers for POCT.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  C-reactive protein; General practice; Point of care

Mesh:

Substances:

Year:  2014        PMID: 25445415     DOI: 10.1016/j.cca.2014.10.028

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  17 in total

1.  Patient Willingness to Have Tests to Guide Antibiotic Use for Respiratory Tract Infections: From the WWAMI Region Practice and Research Network (WPRN).

Authors:  Malaika Schwartz; Victoria Hardy; Gina A Keppel; William Alto; Jaime Hornecker; Beth Robitaille; Jon Neher; John Holmes; M Ashworth Dirac; Allison M Cole; Matthew Thompson
Journal:  J Am Board Fam Med       Date:  2017 Sep-Oct       Impact factor: 2.657

2.  Implementation factor mapping of a pilot study of point-of-care C-reactive protein testing for respiratory tract infections in community pharmacy.

Authors:  Leanne Chalmers; Petra Czarniak; Jeffery Hughes; Rebecca Iacob; Ya Ping Lee; Kiran Parsons; Richard Parsons; Bruce Sunderland; Tin Fei Sim
Journal:  Explor Res Clin Soc Pharm       Date:  2022-06-02

3.  Analytical performance of a platform for point-of-care CRP testing in adults consulting for lower respiratory tract infection in primary care.

Authors:  Veerle Matheeussen; Viviane Van Hoof; Katherine Loens; Christine Lammens; Anouk Vanderstraeten; Samuel Coenen; Chris C Butler; Paul Little; Theo J M Verheij; Herman Goossens; Margareta Ieven
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2018-05-10       Impact factor: 3.267

4.  Assessment of a new point-of-care system for detection of prostate specific antigen.

Authors:  Steffen Rausch; Joerg Hennenlotter; Josef Wiesenreiter; Andrea Hohneder; Julian Heinkele; Christian Schwentner; Arnulf Stenzl; Tilman Todenhöfer
Journal:  BMC Urol       Date:  2016-01-19       Impact factor: 2.264

Review 5.  Biomarkers for Point-of-Care Diagnosis of Sepsis.

Authors:  Andrew Teggert; Harish Datta; Zulfiqur Ali
Journal:  Micromachines (Basel)       Date:  2020-03-10       Impact factor: 2.891

6.  Modelling the Impact and Cost-Effectiveness of Biomarker Tests as Compared with Pathogen-Specific Diagnostics in the Management of Undifferentiated Fever in Remote Tropical Settings.

Authors:  Yoel Lubell; Thomas Althaus; Stuart D Blacksell; Daniel H Paris; Mayfong Mayxay; Wirichada Pan-Ngum; Lisa J White; Nicholas P J Day; Paul N Newton
Journal:  PLoS One       Date:  2016-03-30       Impact factor: 3.240

7.  Performance of C-reactive protein and procalcitonin to distinguish viral from bacterial and malarial causes of fever in Southeast Asia.

Authors:  Yoel Lubell; Stuart D Blacksell; Susanna Dunachie; Ampai Tanganuchitcharnchai; Thomas Althaus; Wanitda Watthanaworawit; Daniel H Paris; Mayfong Mayxay; Thomas J Peto; Arjen M Dondorp; Nicholas J White; Nicholas P J Day; François Nosten; Paul N Newton; Paul Turner
Journal:  BMC Infect Dis       Date:  2015-11-11       Impact factor: 3.090

8.  Accuracy of commercially available c-reactive protein rapid tests in the context of undifferentiated fevers in rural Laos.

Authors:  Koukeo Phommasone; Thomas Althaus; Phonesavanh Souvanthong; Khansoudaphone Phakhounthong; Laxoy Soyvienvong; Phatthaphone Malapheth; Mayfong Mayxay; Rebecca L Pavlicek; Daniel H Paris; David Dance; Paul Newton; Yoel Lubell
Journal:  BMC Infect Dis       Date:  2016-02-04       Impact factor: 3.090

9.  Circulating high sensitivity C reactive protein concentrations and risk of lung cancer: nested case-control study within Lung Cancer Cohort Consortium.

Authors:  David C Muller; Tricia L Larose; Allison Hodge; Florence Guida; Arnulf Langhammer; Kjell Grankvist; Klaus Meyer; Qiuyin Cai; Alan A Arslan; Anne Zeleniuch-Jacquotte; Demetrius Albanes; Graham G Giles; Howard D Sesso; I-Min Lee; J Michael Gaziano; Jian-Min Yuan; Judith Hoffman Bolton; Julie E Buring; Kala Visvanathan; Loic Le Marchand; Mark P Purdue; Neil E Caporaso; Øivind Midttun; Per M Ueland; Ross L Prentice; Stephanie J Weinstein; Victoria L Stevens; Wei Zheng; William J Blot; Xiao-Ou Shu; Xuehong Zhang; Yong-Bing Xiang; Woon-Puay Koh; Kristian Hveem; Cynthia A Thomson; Mary Pettinger; Gunnar Engström; Hans Brunnström; Roger L Milne; Meir J Stampfer; Jiali Han; Mikael Johansson; Paul Brennan; Gianluca Severi; Mattias Johansson
Journal:  BMJ       Date:  2019-01-03

10.  Fluorescent fullerene nanoparticle-based lateral flow immunochromatographic assay for rapid quantitative detection of C-reactive protein.

Authors:  Kyung Mi Park; Da Jung Chung; Mijin Choi; Taejoon Kang; Jinyoung Jeong
Journal:  Nano Converg       Date:  2019-11-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.